In conclusion, our study suggests that, in men affected by postsurgical hypogonadotropic hypogonadism, the shorter length of AR gene CAG tract is associated with an improved metabolic effect of TRT, independently of the effects of other concomitant pituitary-function replacement therapies. This evidence concerns the gene AR and hypogonadotropic hypogonadism.